ANDA 077717

NESHER PHARMS

FDA Drug Application

Application #077717

Application Sponsors

ANDA 077717

NESHER PHARMS

Marketing Status

• Discontinued: 001
• Discontinued: 002

Application Products

001	TABLET, ORALLY DISINTEGRATING;ORAL	4MG	0	ONDANSETRON	ONDANSETRON
002	TABLET, ORALLY DISINTEGRATING;ORAL	8MG	0	ONDANSETRON	ONDANSETRON

FDA Submissions

ORIG

1

TA

2007-05-23

Submissions Property Types

ORIG

1

Null

0

CDER Filings

NESHER PHARMS

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 77717
            [companyName] => NESHER PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ONDANSETRON","activeIngredients":"ONDANSETRON","strength":"4MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ONDANSETRON","activeIngredients":"ONDANSETRON","strength":"8MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ONDANSETRON","submission":"ONDANSETRON","actionType":"4MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"ONDANSETRON","submission":"ONDANSETRON","actionType":"8MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)